Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Prevalence of HIV protease mutations on failure of nelfinavir-containing HAART: a retrospective analysis of four clinical studies and two observational cohorts.
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.
Anti-HIV activity of a novel aminoglycoside-arginine conjugate.
Sequential involvement of Cdk1, mTOR and p53 in apoptosis induced by the HIV-1 envelope.
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens.
Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity.
RNA interference of HIV replication.
Retroviruses and opportunistic infections - ninth conference. New antiviral agents. 24-28 February, Seattle, WA, USA.
Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
CD4(+) and CD8(+) T cell death during human immunodeficiency virus infection in vitro.